pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
pharmadog news

Browse

3,640 stories matching this filter · ← front page

★ save view↓export CSV
rangeto
sort
recentoldestsourcealpha
source
STAT1789Endpoints1393Fierce Biotech712BioSpace702BioPharma Dive526raps234onclive165fda recalls113
therapy area
allOncology12362Rare Disease3231Immunology2872Cardiology2752Hematology2179Pulmonology2149Vaccines
  • CAR-T biotech Kelonia rebounds from cash crises to a $3 billion sale, while drugmakers explore Prescribery partnership
    The latest episode of STAT's "The Readout LOUD" podcast focuses on a dramatic turnaround at a CAR‑T biotech that faced near‑bankruptcy three times before being bought for more than $3 billion. The…
    STAT · 6mo agoPositive↗ source
  • Sanofi defends Garijo appointment and reaffirms commitment to immunology ahead of new CEO
    Sanofi held its first-quarter earnings call, with CFO François-Xavier Roger fielding questions from the media. During the call he defended the recent appointment of Belén Garijo, formerly of Merck…
    Endpoints · 6mo agoEarningsNeutral↗ source
← prev
page 146 of 146
next →
fda medwatch111
globenewswire health73
fda press59
1802
Psychiatry & CNS1204
Ophthalmology1064
Pain778
Endocrinology & Metabolism777
Nephrology762
  • Substance-use disorder biotech Tempero Bio shuts down after serious safety incident
    Tempero Bio, a biotech focused on treatments for substance use disorders, announced it will cease operations. The decision follows a serious adverse event that occurred during the company's develo…
    Endpoints · 6mo agoNegative↗ source
  • Opinion: Dropping the flu vaccine requirement puts U.S. military readiness at risk
    Since the 1918 pandemic, the military has acknowledged the threat of influenza. Now that’s changing.
    STAT · 6mo agoRegulatoryNeutral↗ source
  • Endpoints News earns three Neal Awards for Trump coverage, CRISPR series and JPM event
    Endpoints News was honored with three Neal Awards in 2026. The awards recognize its reporting on the pharmaceutical industry's interactions with the Trump administration, a three-part series explo…
    Endpoints · 6mo agoPositive↗ source
  • Gravity Rail secures $2.75 million seed round to expand AI-driven patient communication platform
    Gravity Rail is a new company that builds artificial intelligence tools to help health care providers manage phone calls, text messages and follow‑up tasks with patients. The platform aims to strea…
    Endpoints · 6mo agoDealPositive↗ source
  • Mouse study links heart's constant beating to a hostile environment for cancer cells
    Heart disease and cancer are leading causes of death, yet tumors are rarely found in the heart, a fact clinicians have noted without clear explanation. Researchers reported in a Science paper that…
    STAT · 6mo agoPositive readoutPositive↗ source
  • Trump nominates former deputy surgeon general Erica Schwartz as CDC director, testing MAHA influence
    President Trump has announced Erica Schwartz, a former deputy surgeon general, as the new CDC director. Schwartz is known for supporting vaccination and is seen as a traditional public‑health choic…
    Endpoints · 6mo agoRegulatoryNeutral↗ source
  • Colorado and Virginia lawmakers block attempts to limit drug affordability boards
    Legislators in Colorado and Virginia are pushing back against proposals to curb the authority of state prescription‑drug affordability boards. In Virginia, the General Assembly voted unanimously t…
    STAT · 6mo agoRegulatoryNeutral↗ source
  • Esther Wojcicki launches AI healthcare residency to aid startup co-founder collaboration
    Esther Wojcicki, often called the godmother of Silicon Valley, is turning her attention to health technology education. She is helping to launch a new AI healthcare residency program aimed at early…
    Endpoints · 6mo agoPositive↗ source
  • Amgen Announces Retirement of Chief Technology Officer David Reese
    Amgen announced that longtime leader David Reese will retire at the end of June. Reese, 63, currently serves as the company's chief technology officer, a position he created in 2023 after many yea…
    Endpoints · 6mo agoNeutral↗ source
  • AbbVie allocates $1.4 billion for new 185-acre manufacturing campus in Durham, NC
    AbbVie has disclosed more details of its $100 billion pledge to the United States, setting aside $1.4 billion to build its first manufacturing campus in North Carolina. The project will cover a 18…
    Endpoints · 6mo agoDealNeutral↗ source
  • OpenAI releases free ChatGPT for Clinicians to assist doctors, nurses and pharmacists
    OpenAI announced the launch of ChatGPT for Clinicians, a free AI‑powered tool designed for use by physicians, nurse practitioners, physician assistants and pharmacists. The service aims to help cl…
    Endpoints · 6mo agoPositive↗ source
  • BridgeBio Oncology appoints CSO Pedro Beltran as CEO, makes Neil Kumar executive chairman
    BridgeBio Oncology Therapeutics announced a leadership reshuffle aimed at strengthening its focus on KRAS-driven cancer programs. The company is replacing CEO Eli Wallace with its chief scientific…
    Endpoints · 6mo agoNeutral↗ source
  • Pharma-backed petition urges FDA to change policy on public release of drug rejection letters
    A law firm representing an unnamed pharmaceutical company has filed a petition asking the FDA to revise its new practice of publishing partially redacted drug rejection letters. The petition argue…
    Endpoints · 6mo agoRegulatoryNegative↗ source